Abstract
Brentuximab Vedotin in Combination with Nivolumab, Doxorubicin, and Dacarbazine in Newly Diagnosed Patients with Advanced Stage Hodgkin Lymphoma (SGN35-027, Trial in Progress)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have